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Abstract
Background: Adipose-derived mesenchymal stem cells (MSCs) have been gaining fame mainly due to their
vast clinical potential, simple isolation methods and minimal donor site morbidity. Adipose-derived MSCs and
microvascular endothelial cells have been shown to bear angiogenic and vasculogenic capabilities. We
hypothesized that co-culture of human adipose-derived MSCs with human adipose-derived microvascular
endothelial cells (HAMECs) will serve as an effective cell pair to induce angiogenesis and vessel-like network
formation in three-dimensional scaffolds in vitro.
Methods: HAMECs or human umbilical vein endothelial cells (HUVECs) were co-cultured on scaffolds with either
MSCs or human neonatal dermal fibroblasts. Cells were immunofluorescently stained within the scaffolds at
different time points post-seeding. Various analyses were performed to determine vessel length, complexity and
degree of maturity.
Results: The HAMEC:MSC combination yielded the most organized and complex vascular elements within scaffolds,
and in the shortest period of time, when compared to the other tested cell combinations. These differences were
manifested by higher network complexity, more tube alignment and higher α-smooth muscle actin expression.
Moreover, these generated microvessels further matured and developed during the 14-day incubation period
within the three-dimensional microenvironment.
Conclusions: These data demonstrate optimal vascular network formation upon co-culture of microvascular
endothelial cells and adipose-derived MSCs in vitro and constitute a significant step in appreciation of the potential
of microvascular endothelial cells and MSCs in different tissue engineering applications that can also be advantageous
in in vivo studies.
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Background
For any engineered tissue, vasculogenesis and angiogenesis
are crucial for integration and survival in vivo [1]. Inad-
equate vascular supply of the engineered tissue will prevent
its assimilation with the host tissue, eventually leading to
its deterioration [2]. Incorporation of bioengineered micro-
vessels in cell-seeded tissue constructs presents a means of
ensuring appropriate oxygen and nutrient exchange and
can facilitate graft integration in vivo [3]. Optimal bioengi-
neered vasculature can be obtained by co-culturing vascular
endothelial cells (ECs) and perivascular cells on three-
dimensional (3D) poly-L-lactic acid (PLLA)/poly-lactic-co-
glycolic acid (PLGA) constructs [2, 4].
Adipose-derived stem cells comprise one of the most
promising stem cell populations identified thus far [5],
primarily due to the ubiquity of adipose tissue, simple
isolation techniques, and minimal donor site morbidity
and patient discomfort [6, 7]. Due to the capacity of its
mesenchymal stem cell (MSC) content to differentiate to
a variety of cell types of the mesodermal lineage [8, 9],
recent tissue engineering applications have integrated
adipose-derived MSCs to achieve regeneration of a
variety of tissue types, including vascular tissues [10, 11].
Many studies have demonstrated vascular formation and
maturation in vitro, mediated by angiogenic factors
secreted by MSCs supporting cultured ECs [10, 12]. The
origin of ECs selected for vascular formation applica-
tions has been suggested to be very important as well,
where adipose-derived microvascular ECs have been
shown to display stronger angiogenic capacities, when
compared to those derived from macrovessels [13, 14].
Our earlier studies have documented generation of
vascular networks within porous biodegradable PLLA/
PLGA constructs embedded with a co-culture of human
umbilical vein endothelial cells (HUVECs) and human
neonatal dermal fibroblasts (HNDFs) [2, 4, 15]. The
present study aimed to monitor vascularization dynam-
ics within 3D PLLA/PLGA scaffolds embedded with ECs
isolated from either micro- or macrovessels, and to
characterize the impact of supporting MSCs or HNDFs
on the recorded vessel formation dynamics. We show
that adipose-derived ECs supported by MSCs generate
more developed vascular networks within 3D constructs
and at a faster rate than other studied cell combinations.
The possibility of using autologous adipose-derived
MSCs [16] combined with microvascular ECs will both
improve the formation rate and quality of vascular
networks and will advance our abilities and potential to
treat large tissue defects [17].
Methods
Cell culture
Adipose-derived MSCs (Bonus BioGroup Ltd., Israel)
were cultivated in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco Life Technologies) supplemented with
10 % fetal bovine serum (FBS; European-grade, Biological
Industries) and 1 % Glutamax (Gibco Life Technologies),
for up to five passages. Human adipose microvascular
endothelial cells (HAMECs; ScienceCell) isolated from
human adipose tissue were cultivated in endothelial cell
medium (ScienceCell) supplemented with 5 % FBS (Scien-
ceCell) and endothelial cell growth supplement (Science-
Cell), and harvested for the experiments during passages
4–8. HUVECs (Lonza) were grown in EGM-2 medium
supplemented with endothelial cell growth medium
BulletKit®-2 (EGM-2® BulletKit®, Lonza) and harvested for
the experiments during passages 4–8. Human foreskin
fibroblast cells (HNDFs; Lonza) were cultured in DMEM
(Gibco Life Technologies) supplemented with 10 % FBS
(Hyclone; Thermo Fisher Scientific), 1 % nonessential
amino acids, and 0.2 % β-mercaptoethanol (Sigma-
Aldrich). All cells were cultured in a 5 % CO2 humidified
incubator at 37 °C.
PLLA/PLGA scaffolds
3D porous biodegradable scaffolds were fabricated utiliz-
ing a salt-leaching technique with salt with a diameter of
212–600 μm, as previously described [18]. This range of
NaCl particle sizes was used to allow formation of a
sufficiently large interconnected pore-size network. At
the same time, the pore size is sufficiently small to main-
tain optimal mechanical strength. The scaffolds were
prepared from a 50 % PLLA (Polysciences) and 50 %
PLGA (Boehringer Ingelheim) solution in chloroform.
The polymer solution (0.24 ml) was added to sodium
chloride particles (0.4 g) maintained in Teflon molds.
The chloroform was allowed to evaporate overnight, and
the salt was then leached out using distilled water,
resulting in interconnected porous 3D scaffolds. The
resulting 1 mm height scaffolds were cut out using a
6 mm diameter puncher to obtain 28.26 mm3 pieces,
which were then soaked in 70 % ethanol (v/v) for
30 min, and washed three times in phosphate-buffered
saline (PBS) for 5 min before use.
Cultivation of cell combinations on PLLA/PLGA scaffolds





Our earlier studies established an optimal ratio of 5:1
between ECs and supporting cells (e.g., MSCs and
HNDFs) [19]. In the present study, this ratio was main-
tained by seeding 0.25 × 106 ECs and 0.05 × 106 support-
ing cells per scaffold. First, the cells were mixed with
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5 μl thrombin solution (Johnson & Johnson Medical,
Israel). The same volume of a human fibrinogen solution
(Johnson & Johnson Medical) was added to the cell-
thrombin mixture, followed by rapid pipetting and seed-
ing upon the PLLA/PLGA scaffolds, which were then
placed on a non-tissue culture six-well plate dish. After
the scaffolds were incubated in a highly humidified 37 °C,
5 % CO2 incubator for 30 min, 2 ml of EC medium, mixed
with 2 ml of respective supporting cell medium (1:1 ratio),
were added. Medium was changed every other day.
Immunofluorescent staining of whole-mount scaffolds
Whole scaffolds were fixated in 4 % paraformaldehyde
(Electron Microscopy Sciences) for 20 min, and then
washed several times with PBS. Next, the scaffolds were
treated with 0.3 % Triton X-100 (Bio Lab Ltd) for
10 min in order to permeabilize the cells. The scaffolds
were washed with PBS and soaked in blocking solution
(10 % FBS (v/v), 0.1 % Triton (v/v), 1 % glycine (w/v))
for 3 h at room temperature. Subsequently, samples
were incubated overnight at 4 °C with the following
primary antibodies (diluted in blocking solution): mono-
clonal mouse anti-human CD31 (1:50, Cell Marque) and
monoclonal rabbit anti-α-smooth muscle actin (α-SMA)
(1:200, Dako). After extensive washing, secondary anti-
bodies (diluted in PBS) were added and incubated with
the sample for 3 h at room temperature: Cy3-conjugated
anti-mouse IgG (1:100, Jackson Immuno-research la-
boratory, PA) and Alexa 488-conjugated anti-rabbit IgG
(1:400, Molecular Probes). The scaffolds were then
stored in PBS until imaging.
Immunofluorescent staining of paraffin-embedded
sections
Whole scaffolds were cut perpendicularly to their hori-
zontal plane (as illustrated in Additional file 1). Several
slices were randomly chosen from the different areas of
the scaffold to provide authentic data for scoring and
analysis. Scaffolds were embedded in paraffin, using a
standard fixation and embedding protocol, and then cut
into 5-μm thick slices and placed on slides for immuno-
fluorescent staining. Slides were incubated in a 60 °C
heater for 30 min to dissolve the paraffin. Next, the
slides were incubated at 95 °C for 20 min in Reveal
Docloaker 10X (Biocare Medical) in a pressure cooker
for epitope retrieval. After cooling, the slices were sub-
merged in a 5 % bovine serum albumin (BSA) solution
(w/v, Millipore) for 30 min. Subsequently, primary anti-
bodies diluted in 5 % BSA solution were applied and
incubated at 4 °C overnight: monoclonal mouse anti-
human CD31 (1:50, Cell Marque) and monoclonal rabbit
anti-α-SMA (1:200, Dako). Sections were washed three
times in PBS for 5 min before being incubated with
the following secondary antibodies: Cy3-conjugated
anti-mouse IgG (1:100, Jackson Immuno-research labora-
tory) and Alexa 488-conjugated anti-rabbit IgG (1:400,
Molecular Probes) at room temperature for 30 min. Sec-
tions were then rinsed three times in PBS for 5 min each
and then cleaned for Fluromount-G (Southern Biotech-
nology) mounting using dry wipers, and covered with
cover slips (#1.5) for slide protection. The slides were then
imaged using a confocal microscope. As this study focused
on cell organizations, we decided to use the CD31 marker
to enhance identification of the endothelial structures.
This marker was chosen as it was expressed in a uniform
manner for both HUVECs and HAMECs, compared to
another commonly used marker (vWF) as shown in
Additional file 2.
Scaffold imaging
Images were captured using a Leica™ TCS LSI super-
zoom macroconfocal microscope. The depth of imaging
was 300–500 microns, and at least 20 Z-stacks. The
seeded side of the scaffold was imaged. A X5 apochro-
matic macro-objective was used for whole-mount con-
struct imaging. After completing whole-mount imaging,
the scaffolds were sliced, as described above, stained
with immunofluorescently labeled antibodies and imaged
via an inverted microscope (Zeiss MTB2004, Carl Zeiss,
Germany). The images were captured using a CCD cam-
era (AxioCam MRm; ×40 lens).
Vessel network development determination
Several regions of vasculature were randomly chosen for
imaging within each scaffold. The various stages of de-
velopment were categorized as: single cells, cell groups,
a moderately developed vessel network, or a fully devel-
oped vessel network. Each development stage was then
graded manually as either 25 %, 50 %, 75 % or 100 % to
indicate its level within the image, thus providing an
indication between the vessel development stage and
given percentage value.
Vessel length quantification using AngioTool
The confocal microscope images were uploaded to
AngioTool (AngioTool®) [20], which is a program capable
of detecting, marking and scoring the average vessel
length (mm). The software marks all detected elements
in red, junctions in blue and vessel borders in yellow.
Vessel network complexity evaluation
Complexity [21] of the formed vessel network within the
3D scaffolds was determined using MATLAB (MATLAB©,
MathWorks). The confocal microscope image was con-
verted to a binary image using the threshold cut. Noise
reduction was performed using erosion followed by dila-
tion, used to restore connectivity to connect 1-pixel neigh-
boring vessels (all morphological operations were done
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using bwmorph). The area and perimeter of the element
detected within the image were then determined using
regionprops. For each element with an area exceeding
30 pixels, a complexity factor was calculated as follows:
Complexity factor ¼ 4πA
P2
; 0 < complexity factor < 1;
Where A is area and P is perimeter. The complexity
factor is 1 for a perfect circle, and very low for complex
branched structure. The various complexities per image
were marked by coloring the elements according to their
complexity factor, using the following scale: single cells
with a rounded shape fell within the high complexity
range of 0.55–1 and were marked in blue, whereas
elongated but non-complex shapes received complexity
values of 0.3–0.55 and were marked in yellow. Optimal
vessel structures, comprised of an elongated and com-
plex vessel network, fell within the low complexity range
of 0–0.3 and were marked in red. Gray elements repre-
sent elements larger than noise size particles.
Vessel orientation determination
Whole-mount-stained scaffolds were imaged by confocal
microscopy. As aligned vessels were distributed at differ-
ent angles within the scaffold, images of different regions
were included in the vessel orientation analysis.
A MATLAB algorithm based on Hough-transform was
used to detect lines within the image and to estimate
their orientation. Histograms of line angle distributions,
at 30-degree intervals ranging from −90 to 90 degrees,
were generated.
A random region of detected lines was imaged in higher
magnification (×5). Following that, MATLAB analysis
generated a histogram of element orientation distribution.
In order to determine whether the vessels demonstrated a
specific direction or orientation, the maximal number of
elements per direction was divided by the total number of
Fig. 1 In vitro vessel-like network formation. Confocal images (scale bars = 1000 μm) of whole-mount PLLA/PLGA scaffolds embedded with a HAMECs
and MSCs, b HUVECs and MSCs, c HAMECs and HNDFs or d HUVECs and HNDFs and stained for CD31 (red) and nuclei (blue), on days 4,
7, 10 and 14 post-seeding. HAMEC Human adipose microvascular endothelial cell, HNDF Human neonatal dermal fibroblast, HUVEC Human
umbilical vein endothelial cell, MSC Mesenchymal stem cell
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elements in the image. Calculations are presented in histo-
grams and compared for all tested cell pairs.
Vessel maturity evaluation by cell marker follow-up
Whole-mount scaffold sections were labeled with anti-
bodies against human CD31 (presented in green) and
human α-SMA (presented in red), as described above, and
imaged with an inverted microscope (Zeiss MTB2004,
Carl Zeiss, Germany), using a 40× objective to identify
vessel lumens. Several regions within each section were
randomly selected. Image J [22] was used to observe the
complete image. Lumens with a diameter larger than 35
microns, that may represent rounded structures that cover
the scaffold pores, were excluded from the analysis. After
locating the lumens for analysis, the image was split into
two separate channels: red and green. The green-labeled
vessel perimeter and then the red-labeled vessel fragments
were manually marked within the software. The percent-
age of the summed length of red fragment versus the
summed lumen perimeters was calculated. Each image
included an average of 2–3 lumens; the average percent-
age of α-SMA staining with respect to the total lumen
perimeter was calculated for each image.
Statistical analysis
Presented data include the mean ± standard error of
the mean. Two-way analysis of variance (ANOVA) was
performed to examine the influence of two independent
categorical variables followed by Bonferroni’s multiple
comparison tests. Results were considered significant
for p < 0.05. Statistical analyses were performed using a
computerized statistical program (GraphPad Software,
Inc.).
Results
Vessel-like network development on PLLA/PLGA
constructs
In an effort to comprehend how vessel networks develop
during in vitro culture, fluorescently stained HAMECs and
HUVECs grown in various co-culture combinations on 3D
PLLA/PLGA matrices were tracked over a 14-day period
using confocal microscopy. After 4 days in culture, cells in
HAMEC:MSC (Fig. 1a) combinations began to form elon-
gated structures, while those in the HUVEC:MSC (Fig. 1b),
HAMEC:HNDF (Fig. 1c) and HUVEC:HNDF (Fig. 1d)
combinations formed clusters. Well-developed vessel-
like networks of HAMECs:MSCs were already observed
on day 7 (Fig. 1a), and were maintained throughout the
remainder of the experiment. On day 7, HUVECs:MSCs
began to form elongated structures, which failed to pros-
per (Fig. 1b). HAMECs:HNDFs and HUVECs:HNDFs
successfully formed fully developed networks on day 14
only (Fig. 1c and Fig. 1d).
Fig. 2 Vessel-like network development in vitro. a Schematic illustration of four stages of developing vessels: single cells, clusters, initial vessels
and advanced vessels. The stages for development were manually scored using a percentage scale (0–100 %), where a higher percentage was
given to more developed vessel-like networks. b Comparison of vessel development in scaffolds bearing different cell combinations, assessed at
different time points in culture. Two-way ANOVA, p value = 0.0297, n ≥ 4. *p < 0.05, **p < 0.01. HAMEC Human adipose microvascular endothelial
cell, HNDF Human neonatal dermal fibroblast, HUVEC Human umbilical vein endothelial cell, MSC Mesenchymal stem cell
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Vessel network development analysis
The prevalence of vessel development stages, depicted in
Fig. 2a, in randomly imaged segments was determined. By
day 7, the HAMEC:MSC combination yielded organized
and established vessel networks lacking cell clusters and
separate single cells (Fig. 2b), while other groups formed
moderately developed networks (p < 0.05) that comprised
both clusters and many single cells, as well as initial
vessel structures surrounded by single cells. In addition,
aside from the HAMEC:MSC combination, which demon-
strated and maintained complex vessel structure from
early stages, vessel maturity gradually increased in all
groups (Fig. 2b). On days 7, 10 and 14, development stages
of vessel networks formed by the HAMEC:MSC combin-
ation were significantly high (80–100 %), when com-
pared to other group combinations (60–90 %; p = 0.0294)
(Fig. 2b).
Vessel length quantification
In vitro vessel formation on PLLA/PLGA constructs
imaged by a confocal microscope (Fig. 3a) was then
analyzed using a computational tool for quantitative ana-
lysis of vascular network parameters (AngioTool [20])
(Fig. 3b). All cell combinations developed vessels of a
Fig. 3 Representative images of AngioTool analysis and average vessel length determination. a Representative images (scale bars = 250 μm) of
i single cells and ii developed vessel-network embedded within scaffolds, as captured through a confocal microscope. b The AngioTool program
marks the i single cells (red) or ii developed vessels (red), junctions (blue) and vessel borders (yellow). c Average vessel length for different cell
combinations was then determined. Two-way ANOVA, p value = 0.016, n≥ 3. *p < 0.05, ***p < 0.001. HAMEC Human adipose microvascular endothelial
cell, HNDF Human neonatal dermal fibroblast, HUVEC Human umbilical vein endothelial cell, MSC Mesenchymal stem cell
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mean length of ~55 microns 4 days post-seeding; how-
ever, within 7 days the HAMEC:MSC group generated
vessels of an average length of 150 microns, while other
cell combinations maintained a length of ~55 microns
(p < 0.001; Fig. 3c). HAMEC:MSC vessel length was main-
tained at 150 microns for up to day 14 (Fig. 3c).
Other cell combinations developed gradually from a
length of ~55 microns on day 7, to ~100 microns on
day 10 and finally reached ~100–150 microns 14 days
post-seeding (Fig. 3c).
Vessel network complexity
Network complexity was then evaluated with a self-
written algorithm as demonstrated in Fig. 4. On day 4,
the HAMECs:MSCs cell combination formed more
elongated than rounded shapes, when compared to other
Fig. 4 MATLAB analysis of vessel network complexity. MATLAB analysis of confocal images (scale bars = 250 μm) (i) generated new images
(ii) showing vascular network elements (grey), upon which differently colored complexity factor values are presented. These values were divided
into three broad ranges: a red <0.3, yellow 0.3–0.55 and blue >0.55. b Blue elements represent rounded single cells and yellow elements the more
elongated structures. c Blue and yellow elements represent rounded cells and elongated structures, respectively, combined with more red
elements, representing long and complex vessels. d Dominance of red elements representing long and complex vessels and less yellow and
blue elements for rounded shapes
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cell combinations (60 % vs. 40 %, p < 0.001; Fig. 5a). In
contrast, the other cell pairs showed no statistically sig-
nificant differences between the three complexity value
ranges. On day 7, the HAMEC:MSC combination
showed more elongated shapes in comparison to other
groups (60 % vs. 50 %, p = 0.003; Fig. 5b). On day 10, no
statistically significant differences in complexity values
were observed between the tested groups (~60 % for all
groups, p = 0.055; Fig. 5c). On day 14, ~90 % of the
HAMEC:MSC-embedded scaffold elements exhibited
elongated shapes, while complexity values equal to those
recorded on day 10 were measured for the HUVEC:MSC
and HAMEC:HNDF groups on day 14 (p < 0.001). The
HUVEC:HNDF group exhibited more rounded than
elongated shapes on day 14 (Fig. 5d).
In vitro vessel alignment as an indication of vessel
maturity
One phenomenon that has been seen in the present
study of whole-stained co-cultured scaffolds during
vessel development over time is the ability of vessels
to spontaneously align with proximal vessels in the
scaffolds. Vessel-orientation directions were distributed
randomly within the scaffold; thus, several random seg-
ment were imaged and assessed. Up to day 14, orientation
preference was only observed among 20 % of the detected
elements in all cell pairs (Fig. 6f ). However, on day
14 the HAMEC:MSC combination showed an orienta-
tion preference among 40 % of the detected elements
per field of view (Fig. 6f ), while other cell combina-
tions only showed an orientation preference among
20 % of elements (p < 0.0001; Fig. 6f ).
α-SMA expression as an indicator for vessel maturity
To assess vessel maturity, α-SMA and CD31 biomarkers
were labeled and analyzed under a fluorescence microscope
(Fig. 7a). From day 4 until day 14, in the HAMEC:MSC
group, 80 % of the total perimeter of detected lumens were
α-SMA-positive, while other cell combination expressed
significantly less α-SMA (40–60 %; p < 0.001) (Fig. 7b).
In addition, the HUVEC:MSC group showed the low-
est relative α-SMA expression on all tested days
(Fig. 7b) when compared to other cell combinations.
Fig. 5 Distribution of complexity factor ranges for the different cell pairs. The complexity factor of networks within cell-embedded scaffolds was
determined on days 4, 7, 10 and 14 post-seeding. The distribution of complexity factors per cell pair and per day of analysis is presented. a Day 4
(p < 0.001. b Day 7 (p = 0.003). c Day 10 (p = 0.055). d Day 14 (p < 0.001). Two-way ANOVA, n ≥ 3. *p < 0.05, **p < 0.01, ***p < 0.001. HAMEC Human
adipose microvascular endothelial cell, HNDF Human neonatal dermal fibroblast, HUVEC Human umbilical vein endothelial cell, MSC Mesenchymal
stem cell
Freiman et al. Stem Cell Research & Therapy  (2016) 7:5 Page 8 of 12
The HUVEC:HNDF group followed the HAMEC:MSC
group in its relative α-SMA expression levels (Fig. 7b).
Discussion
As bioengineered tissues require mature blood vessels
for optimal functionality and integration in vivo [3, 15],
understanding the vessel formation process is important
to promote and optimize vessel creation in vitro. The
present study demonstrated how the use of adipose-
derived stem cells combined with microvascular ECs
enhances and upgrades vessel network formation in vitro.
This combination led to rapid development of vasculature
with highly complex networks that expressed mature
vessel biomarkers which even became aligned as they
developed.
Numerous studies have shown that adipose-derived
microvascular ECs comprise a rich source of pro-
angiogenic factors, such as vascular endothelial growth
factor and basic fibroblast growth factor [14, 23, 24].
In addition, compared to macrovessels (aortic ECs or
umbilical vein ECs), microvascular ECs secrete more
angiogenic factors as a result of the physiological na-
ture of adipose tissue [14, 25]. Addition of MSCs has
been suggested to improve vascularization by secretion
of more angiogenic markers than fibroblasts [26–28].
The presented findings further strengthen the well-
established notion regarding MSC-driven promotion of
Fig. 6 Vessel alignment as an indication of vessel maturity. a Representative image of half of a scaffold showing different regions with orientated
vessels (scale bar = 500 μm). b Magnified image of vessels orientated in a specific direction (scale bar = 100 μm) and c a histogram showing the
distribution of the elements orientation in image b (represented by different angles). d A magnified image of non-oriented vessels (scale bar =
100 μm) and e a histogram showing the distribution of the elements orientation in image d (represented by different angles). f Statistical analysis
of the number of elements in a given direction versus the total number of elements (%) in each field of view. Two-way ANOVA, Bonferroni’s
multiple comparisons test, n≥ 4. ****p < 0.0001. HAMEC Human adipose microvascular endothelial cell, HNDF Human neonatal dermal fibroblast,
HUVEC Human umbilical vein endothelial cell, MSC Mesenchymal stem cell
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vascular formation within 3D scaffolds, as well as the
ability of microvascular ECs to effectively form vessels.
In earlier studies with a HUVEC:HNDF combin-
ation, cell clusters formed which then continuously
sprouted and formed microvessels [4, 29]. In contrast,
the HAMEC:MSC combination studied here formed
microvessels within the first few days in culture, with-
out cluster organization, which then rapidly formed
vascular networks. These observations suggest a
unique role played by adipose MSCs in facilitating
and promoting angiogenic potential beyond those ob-
served with HNDFs [30]. In addition, compared to
macrovessels (aortic ECs or umbilical vein ECs),
microvascular ECs secrete more angiogenic factors as
a result of the physiological nature of adipose tissue
[14, 25, 31]. These differences were manifested here
in the significantly different time course of vascular
development and maturation in samples containing
HAMECs versus HUVECs.
Within 7 days of seeding, the HAMEC:MSC-embed-
ded scaffolds featured vessels of an average length of 150
microns, which corresponds to the length of the longest
vascular structures measured within a heterogeneous
mixture of adipose-derived arterioles, capillaries, and
venules [32, 33]. In contrast, the other cell combinations
reached this length only 14 days post-seeding. We
suggest that vessels formed in vitro can reach natural
dimensions and characteristics that can be beneficial for
future in vivo and clinical studies.
Furthermore, vessel formation and elongation in the
HAMEC:MSC group occurred within 4 days of culture
and reached maximal complexity on day 14. Other
cell combinations did not display network complex as
high as the HAMEC:MSC group. In addition, a larger
number of oriented vessel segments were observed in
the HAMEC:MSC scaffolds, indicating vessel matur-
ation [15]. As vessel alignment typically occurs in vitro
following external strain and stress cues on the cell-
seeded scaffold [34–36] but formed spontaneously in the
present study, we suggest further investigation of this
process. In order to further investigate vessel develop-
ment, we aimed to track an accessible biological cell
marker indicative of their maturity. Newly formed vessels
are initially created by the ECs [37]. However, as vessels
mature the presence of α-SMA increases due to the
recruitment of supporting cells such as HNDFs or MSCs
[38, 39]. As maturation continues, vessel walls become
rich either in smooth muscle cells, myofibroblasts or
Fig. 7 Evaluation of vessel maturity using cell markers. a Paraffin-embedded sections (5 μm) of cell-embedded PLLA/PLGA scaffolds were fluorescently
labeled for i α-SMA (red) and ii CD31 (green) (scale bars = 20 μm). iii A merged image is presented for α-SMA and CD31 staining (scale bar = 20 μm).
b Statistical analysis of α-SMA coverage out of the overall lumen perimeter, determined by CD31 staining, was performed for vessels under 35 μm in
diameter. Two-way ANOVA, Tukey’s multiple comparisons test, n≥ 4. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. α-SMA Alpha-smooth muscle
actin, HAMEC Human adipose microvascular endothelial cell, HNDF Human neonatal dermal fibroblast, HUVEC Human umbilical vein endothelial cell,
MSC Mesenchymal stem cell
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pericytes that express α-SMA [34, 40]. Therefore, α-SMA
has become an accepted marker of vessel maturity. The
presented data demonstrate that between days 4–14 in
culture, the HAMEC:MSC-embedded scaffolds expressed
more α-SMA than any other cell combination.
Conclusions
Taken together, adipose-derived stem cells combined with
microvascular ECs demonstrate powerful angiogenic and
vasculogenic capabilities. We assume that highly complex
vessel networks within engineered tissues will improve
integration within the host tissue. Moreover, EC-MSC-
embedded scaffolds may present an appropriate model for
studying angiogenesis under physiologically relevant con-
ditions. In addition, engineering of vascularized scaffolds
can be effectively upgraded by integrating easily harvest-
able human adipose cells that include MSCs and micro-
vascular ECs which can be advantageous in many in vivo
applications toward treatment of tissue loss or defects
requiring rapid vasculogenesis, and in design of effective
tissue engineering solutions.
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Additional file 1: Figure S1. Whole PLLA/PLGA scaffolds were cut
perpendicularly to their horizontal plane into 5-micron sections.
(DOCX 60 kb)
Additional file 2: Figure S2. CD31 vs. vWF distribution in ECs of
different origins. Paraffin-embedded sections (5 μm) of HAMECs:MSCs
and HUVECs:HNDFs cultured for 7 days on PLLA/PLGA scaffolds, were
stained for Ai DAPI (blue), Aii vWF (red) and Aiii CD31 (green) (scale
bars = 50 μm). Aiv A merged image of the DAPI, vWF and CD31 staining
is presented (Scale bar = 50 μm). Lumens are indicated with white arrows.
(DOCX 209 kb)
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